-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Currently across the United States has begun mass vaccination new crown vaccine, and for Disease Control and Prevention (CDC Center ) immune Practice Advisory Committee (ACIP ) and the National Academy of Sciences, Academy of Engineering and the Medical Department (NASEM ) on how the equitable distribution of the new crown vaccines have built a preliminary framework: First, Health care workers and residents of long-term care facilities receive the initial dose ( Phase 1a ), followed by those over 75 years of age and frontline workers ( Phase 1b ), and finally those aged 65-74 and those in high-risk medical working conditions ( Phase 1c ) ).
Currently across the United States has begun mass vaccination new crown vaccine, and for Disease Control and Prevention (CDC Center ) immune Practice Advisory Committee (ACIP ) and the National Academy of Sciences, Academy of Engineering and the Medical Department (NASEM ) on how the equitable distribution of the new crown vaccines have built a preliminary framework: First, Health care workers and residents of long-term care facilities receive the initial dose ( Phase 1a ), followed by those over 75 years of age and frontline workers ( Phase 1b ), and finally those aged 65-74 and those in high-risk medical working conditions ( Phase 1c ) ).
As the new crown vaccination work progresses, policy makers are faced with many open questions about how to allocate the vaccine, such as what is the relative priority of basic staff, healthy elderly, and people with high-risk medical conditions? Should priority be given to the socially and economically disadvantaged groups that are overly affected by the new coronavirus? Public participation helps to answer such questions, and also helps to determine the gap between public values and proposed priority programs.
In order to make up for this vacancy, researchers recently surveyed two representative samples of American adults to understand the priority order of the new crown vaccine allocation.
The research is mainly based on previous investigations.
A total of 4735 people participated in this survey.
Respondents from all political factions agreed to give priority to blacks, Hispanics, Native Americans, and other community groups that are more affected by the new crown virus.
In short, American adults generally agree with the priority framework established by the National Academy of Sciences, the Academy of Engineering, and the School of Medicine.
U.
Give priority to giving priority to people of color communities The survey respondents strongly support giving priority to teachers and childcare workers .
The public is more supportive of the prioritization method where multiple value factors work together.
Persad G, Emanuel EJ, Sangenito S, Glickman A, Phillips S, Largent EA.
Public Perspectives on COVID-19 Vaccine Prioritization.
COVID-19 JAMA Netw Open.
2021;4(4):e217943.
doi com/journals/jamanetworkopen/fullarticle/2778340" target="_blank" rel="noopener">:10.
1001/jamanetworkopen.
2021.
7943com/journals/jamanetworkopen/fullarticle/2778340" target="_blank" rel="noopener"> doi:10.
1001/jamanetworkopen.
2021.
7943
leave a message here